Gregory Moseley, Stephen Rawlinson and David Jans at Monash University in Australia will engineer a live virus with a self-destruct sequence for use in a vaccine. This virus would be identical to a wild-type virus, but contain destabilizing domains fused to key proteins that can be regulated to first allow the virus to replicate and induce an immune response, and then be destroyed.
Grant ID
OPP1015572
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False